Wells et al. (2022) established an in vivo mouse model of echovirus infection via the enteral route and defined the roles of the type III interferons, IFNL2 and IFNL3, in controlling viral replication in the intestine using murine-derived primary enteroids. Here, IFNL2 is linked to Echovirus infectious disease.